These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A case of paliperidone-palmitate-induced tardive dyskinesia. Lally J; Byrne F; Walsh E Gen Hosp Psychiatry; 2013; 35(2):213.e5-7. PubMed ID: 22703608 [TBL] [Abstract][Full Text] [Related]
10. Rabbit syndrome following discontinuation of paliperidone in a patient with schizoaffective disorder. Liang CS; Yang FW; Huang YC J Clin Psychopharmacol; 2012 Oct; 32(5):720-1. PubMed ID: 22926613 [No Abstract] [Full Text] [Related]
11. Possible paliperidone-related pons infarction. Chang CC; Wang WF; Lai TJ J Neuropsychiatry Clin Neurosci; 2014; 26(1):E15-6. PubMed ID: 24515693 [No Abstract] [Full Text] [Related]
13. Oral-paliperidone-induced tardive dyskinesia: a case report. Wei HT; Lai YW; Chen MH; Chen YS Gen Hosp Psychiatry; 2012; 34(5):578.e5-6. PubMed ID: 22154659 [TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study. Davidson M; Emsley R; Kramer M; Ford L; Pan G; Lim P; Eerdekens M Schizophr Res; 2007 Jul; 93(1-3):117-30. PubMed ID: 17466492 [TBL] [Abstract][Full Text] [Related]
20. Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone. Teng PR; Lane HY J Neuropsychiatry Clin Neurosci; 2011; 23(4):E16-7. PubMed ID: 22231327 [No Abstract] [Full Text] [Related] [Next] [New Search]